CTOs on the Move

Counsel Wealth Management - IPC

www.counselwealth.com

 
Counsel Wealth Management - IPC is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Gillette Children's Specialty Health

Gillette Children's Specialty Health is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Gillette Children's Specialty Health is based in Saint Paul, MN. You can find more information on Gillette Children's Specialty Health at www.gillettechildrens.com

Blue Cross Blue Shield of Kansas City (BCBSKC)

Blue Cross Blue Shield of Kansas City (BCBSKC) is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Blue Cross Blue Shield of Kansas City (BCBSKC) is based in Kansas City, MO. You can find more information on Blue Cross Blue Shield of Kansas City (BCBSKC) at www.bcbskc.com

Inhealth Record Systems

Inhealth Record Systems is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RecordFlow

RecordFlow is a Tustin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Massive Bio

Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers​ experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.